Stage III Prostate Cancer: Clinical Trials

2 trials for Stage III Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Stage III Prostate Cancer: new trials by email Literature Review of Stage III Prostate Cancer trials Research Report on Stage III Prostate Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Laboratory Biomarker Analysis, Nanoparticle Albumin-Bound Rapamycin, Quality-of-Life Assessment - Advanced Malignant Neoplasm, Cervical Squamous Cell Carcinoma
Early Phase 1CompletedMayo Clinic22016-01-012019-06-06
Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
magnetic resonance imaging, fluorine F 18 sodium fluoride, positron emission tomography - Bone Metastases, Recurrent Prostate Cancer
Early Phase 1CompletedNational Cancer Institute (NCI)502010-03-012014-07-02

Narrower conditions

Prostatic Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Endometrial Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Recurrence (1)  ·  Urinary Bladder Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)  ·  Uterine Neoplasms (1)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Disease Attributes (1)  ·  Endocrine Gland Neoplasms (1)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Technetium Tc 99m Medronate (1)

Sponsors

Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Mitesh Borad (1)  ·  Mukesh Harisinghani (1)

NIH funding

N01CM37120 (1), P30CA006516 (1), P30CA015083 (1)